Materna Medical
PrivateLast Round
Series B
Extension
Jul 1, 2026
Total Funding Raised
$93.38M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Materna Medical operates in Healthcare & Life Sciences and is based in Mountain View, California. Its latest recorded funding round was a Series B Extension round in July 2026.
Materna Medical is a healthcare technology company that develops medical devices aimed at empowering women to protect and restore their pelvic health during labor and delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Patient Engagement
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Materna Medical Comparables
Compare Materna Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axena Health | 82% | |
| Willow Innovations, Inc. | 77% | |
| Utah Medical Products Inc | 73% |
For institutional investors. Book with your work email.
Materna Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 1, 2026 | ||||
| Series B Extension | Jul 10, 2025 | ||||
| Series B Extension | May 23, 2024 | ||||
| Series B | Aug 8, 2022 | ||||
| Series A Extension | Jul 27, 2021 | ||||
Series A | Apr 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Materna Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kimera | Series B Extension, Series A |
| InnovaHealth Partners | Series B Extension, Series B |
| NIH RADx | Grant |
| Black Capital | Series A, Series A Extension |
| Astia Angels | Series A Extension |
| Citrine Angels | Series B Extension |
| Wavemaker Three-Sixty Health | Series B Extension, Series B, Series A, Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
$5M round led by InnovaHealth Partners and Wavemaker Three-Sixty Health.
- Oct 1, 2025
Interim data presented on dilation therapy for painful sex conditions.
For institutional investors. Book with your work email.
Materna Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Materna Medical's valuation, stock price, and market status.
Is Materna Medical a public or private company?
Materna Medical is a private company.
What is the current stock price of Materna Medical?
Materna Medical is a private company, so its shares have no public market price. Caplight tracks Materna Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Materna Medical worth (valuation)?
Valuation information for Materna Medical is not publicly available.
Can I buy Materna Medical stock?
Materna Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Materna Medical's last funding round?
Materna Medical's most recent funding round was Series B Extension on July 1, 2026.
Who are the main investors in Materna Medical?
Key investors in Materna Medical include InnovaHealth Partners, Wavemaker Three-Sixty Health, Band of Angels.
Will Materna Medical IPO soon?
No public IPO plans have been announced for Materna Medical.
How can I track Materna Medical secondary market activity?
Caplight tracks bids, offers, and trades in Materna Medical's shares on secondary markets.